Maslowski and colleagues [18] found that GPR43 activation by SCFAs was necessary for the normal resolution of some inflammatory responses, with GPR43-deficient (Gpr43−/−) mice showing an inability to resolve inflammation in models of colitis, arthritis, and asthma. This evidence concerns the gene FFAR2 and arthritic joint disease.